Patient and disease characteristics in a small CAD cohort
Patient and disease characteristics in a small C
Cold agglutinin disease: on the road to new insights and potential treatment options
Cold agglutinin disease: on the road to new insi
Targeted approaches in various B-cell malignancies
Targeted approaches in various B-cell malignanci
Changing paradigms in the management of mantle cell lymphoma
Changing paradigms in the management of mantle c
Optimizing timing, efficacy and tolerability in chronic lymphocytic leukemia
Optimizing timing, efficacy and tolerability in
Waldenström’s macroglobulinemia: BTK inhibition and other treatments
Waldenström’s macroglobulinemia: BTK inhibition
Small-cell lung cancer: moving the limits further
Small-cell lung cancer: moving the limits furthe
Rare mutations: HER2, RET, ALK, BRAF
Rare mutations: HER2, RET, ALK, BRAF DESTINY
COVID-19 in patients with thoracic cancers: TERAVOLT
COVID-19 in patients with thoracic cancers: TERA
Present and future perspectives of anti-angiogenic therapy
Present and future perspectives of anti-angiogen
